Copyright Reports & Markets. All rights reserved.

Global Neurological Disorder Drugs Sales Market Report 2021

Request for Sample of this report
Buy now

1 Neurological Disorder Drugs Market Overview

  • 1.1 Neurological Disorder Drugs Product Scope
  • 1.2 Neurological Disorder Drugs Segment by Type
    • 1.2.1 Global Neurological Disorder Drugs Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Antipsychotic
    • 1.2.3 Hypnotic & Sedative
    • 1.2.4 Analgesics
    • 1.2.5 Anticoagulants
    • 1.2.6 Others
  • 1.3 Neurological Disorder Drugs Segment by Application
    • 1.3.1 Global Neurological Disorder Drugs Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
  • 1.4 Neurological Disorder Drugs Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Neurological Disorder Drugs Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Neurological Disorder Drugs Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Neurological Disorder Drugs Price Trends (2016-2027)

2 Neurological Disorder Drugs Estimates and Forecasts by Region

  • 2.1 Global Neurological Disorder Drugs Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Neurological Disorder Drugs Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Neurological Disorder Drugs Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Neurological Disorder Drugs Revenue Market Share by Region (2016-2021)
  • 2.3 Global Neurological Disorder Drugs Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Neurological Disorder Drugs Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Neurological Disorder Drugs Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Neurological Disorder Drugs Estimates and Projections (2016-2027)
    • 2.4.2 Europe Neurological Disorder Drugs Estimates and Projections (2016-2027)
    • 2.4.3 China Neurological Disorder Drugs Estimates and Projections (2016-2027)
    • 2.4.4 Japan Neurological Disorder Drugs Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Neurological Disorder Drugs Estimates and Projections (2016-2027)
    • 2.4.6 India Neurological Disorder Drugs Estimates and Projections (2016-2027)

3 Global Neurological Disorder Drugs Competition Landscape by Players

  • 3.1 Global Top Neurological Disorder Drugs Players by Sales (2016-2021)
  • 3.2 Global Top Neurological Disorder Drugs Players by Revenue (2016-2021)
  • 3.3 Global Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Disorder Drugs as of 2020)
  • 3.4 Global Neurological Disorder Drugs Average Price by Company (2016-2021)
  • 3.5 Manufacturers Neurological Disorder Drugs Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Neurological Disorder Drugs Market Size by Type

  • 4.1 Global Neurological Disorder Drugs Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Neurological Disorder Drugs Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Neurological Disorder Drugs Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Neurological Disorder Drugs Price by Type (2016-2021)
  • 4.2 Global Neurological Disorder Drugs Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Neurological Disorder Drugs Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Neurological Disorder Drugs Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Neurological Disorder Drugs Price Forecast by Type (2022-2027)

5 Global Neurological Disorder Drugs Market Size by Application

  • 5.1 Global Neurological Disorder Drugs Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Neurological Disorder Drugs Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Neurological Disorder Drugs Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Neurological Disorder Drugs Price by Application (2016-2021)
  • 5.2 Global Neurological Disorder Drugs Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Neurological Disorder Drugs Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Neurological Disorder Drugs Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Neurological Disorder Drugs Price Forecast by Application (2022-2027)

6 North America Neurological Disorder Drugs Market Facts & Figures

  • 6.1 North America Neurological Disorder Drugs Sales by Company
    • 6.1.1 North America Neurological Disorder Drugs Sales by Company (2016-2021)
    • 6.1.2 North America Neurological Disorder Drugs Revenue by Company (2016-2021)
  • 6.2 North America Neurological Disorder Drugs Sales Breakdown by Type
    • 6.2.1 North America Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
  • 6.3 North America Neurological Disorder Drugs Sales Breakdown by Application
    • 6.3.1 North America Neurological Disorder Drugs Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Neurological Disorder Drugs Sales Breakdown by Application (2022-2027)

7 Europe Neurological Disorder Drugs Market Facts & Figures

  • 7.1 Europe Neurological Disorder Drugs Sales by Company
    • 7.1.1 Europe Neurological Disorder Drugs Sales by Company (2016-2021)
    • 7.1.2 Europe Neurological Disorder Drugs Revenue by Company (2016-2021)
  • 7.2 Europe Neurological Disorder Drugs Sales Breakdown by Type
    • 7.2.1 Europe Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Neurological Disorder Drugs Sales Breakdown by Application
    • 7.3.1 Europe 115 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 115 Sales Breakdown by Application (2022-2027)

8 China Neurological Disorder Drugs Market Facts & Figures

  • 8.1 China Neurological Disorder Drugs Sales by Company
    • 8.1.1 China Neurological Disorder Drugs Sales by Company (2016-2021)
    • 8.1.2 China Neurological Disorder Drugs Revenue by Company (2016-2021)
  • 8.2 China Neurological Disorder Drugs Sales Breakdown by Type
    • 8.2.1 China Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
  • 8.3 China Neurological Disorder Drugs Sales Breakdown by Application
    • 8.3.1 China 142 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 142 Sales Breakdown by Application (2022-2027)

9 Japan Neurological Disorder Drugs Market Facts & Figures

  • 9.1 Japan Neurological Disorder Drugs Sales by Company
    • 9.1.1 Japan Neurological Disorder Drugs Sales by Company (2016-2021)
    • 9.1.2 Japan Neurological Disorder Drugs Revenue by Company (2016-2021)
  • 9.2 Japan Neurological Disorder Drugs Sales Breakdown by Type
    • 9.2.1 Japan Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Neurological Disorder Drugs Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Neurological Disorder Drugs Market Facts & Figures

  • 10.1 Southeast Asia Neurological Disorder Drugs Sales by Company
    • 10.1.1 Southeast Asia Neurological Disorder Drugs Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Neurological Disorder Drugs Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Type
    • 10.2.1 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Neurological Disorder Drugs Market Facts & Figures

  • 11.1 India Neurological Disorder Drugs Sales by Company
    • 11.1.1 India Neurological Disorder Drugs Sales by Company (2016-2021)
    • 11.1.2 India Neurological Disorder Drugs Revenue by Company (2016-2021)
  • 11.2 India Neurological Disorder Drugs Sales Breakdown by Type
    • 11.2.1 India Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
  • 11.3 India Neurological Disorder Drugs Sales Breakdown by Application
    • 11.3.1 India Neurological Disorder Drugs Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Neurological Disorder Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Neurological Disorder Drugs Business

  • 12.1 Novartis
    • 12.1.1 Novartis Corporation Information
    • 12.1.2 Novartis Business Overview
    • 12.1.3 Novartis Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Novartis Neurological Disorder Drugs Products Offered
    • 12.1.5 Novartis Recent Development
  • 12.2 GlaxoSmithKline
    • 12.2.1 GlaxoSmithKline Corporation Information
    • 12.2.2 GlaxoSmithKline Business Overview
    • 12.2.3 GlaxoSmithKline Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 GlaxoSmithKline Neurological Disorder Drugs Products Offered
    • 12.2.5 GlaxoSmithKline Recent Development
  • 12.3 Merck & Co.
    • 12.3.1 Merck & Co. Corporation Information
    • 12.3.2 Merck & Co. Business Overview
    • 12.3.3 Merck & Co. Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Merck & Co. Neurological Disorder Drugs Products Offered
    • 12.3.5 Merck & Co. Recent Development
  • 12.4 Bayer
    • 12.4.1 Bayer Corporation Information
    • 12.4.2 Bayer Business Overview
    • 12.4.3 Bayer Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Bayer Neurological Disorder Drugs Products Offered
    • 12.4.5 Bayer Recent Development
  • 12.5 AstraZeneca
    • 12.5.1 AstraZeneca Corporation Information
    • 12.5.2 AstraZeneca Business Overview
    • 12.5.3 AstraZeneca Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 AstraZeneca Neurological Disorder Drugs Products Offered
    • 12.5.5 AstraZeneca Recent Development
  • 12.6 Boehringer Ingelheim
    • 12.6.1 Boehringer Ingelheim Corporation Information
    • 12.6.2 Boehringer Ingelheim Business Overview
    • 12.6.3 Boehringer Ingelheim Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Boehringer Ingelheim Neurological Disorder Drugs Products Offered
    • 12.6.5 Boehringer Ingelheim Recent Development
  • 12.7 Teva Pharmaceutical
    • 12.7.1 Teva Pharmaceutical Corporation Information
    • 12.7.2 Teva Pharmaceutical Business Overview
    • 12.7.3 Teva Pharmaceutical Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Teva Pharmaceutical Neurological Disorder Drugs Products Offered
    • 12.7.5 Teva Pharmaceutical Recent Development

...

    13 Neurological Disorder Drugs Manufacturing Cost Analysis

    • 13.1 Neurological Disorder Drugs Key Raw Materials Analysis
      • 13.1.1 Key Raw Materials
      • 13.1.2 Key Raw Materials Price Trend
      • 13.1.3 Key Suppliers of Raw Materials
    • 13.2 Proportion of Manufacturing Cost Structure
    • 13.3 Manufacturing Process Analysis of Neurological Disorder Drugs
    • 13.4 Neurological Disorder Drugs Industrial Chain Analysis

    14 Marketing Channel, Distributors and Customers

    • 14.1 Marketing Channel
    • 14.2 Neurological Disorder Drugs Distributors List
    • 14.3 Neurological Disorder Drugs Customers

    15 Market Dynamics

    • 15.1 Neurological Disorder Drugs Market Trends
    • 15.2 Neurological Disorder Drugs Drivers
    • 15.3 Neurological Disorder Drugs Market Challenges
    • 15.4 Neurological Disorder Drugs Market Restraints

    16 Research Findings and Conclusion

      17 Appendix

      • 17.1 Research Methodology
        • 17.1.1 Methodology/Research Approach
        • 17.1.2 Data Source
      • 17.2 Author List

      The global Neurological Disorder Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurological Disorder Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

      Segment by Type
      Antipsychotic
      Hypnotic & Sedative
      Analgesics
      Anticoagulants
      Others

      Segment by Application
      Hospital
      Clinic

      The Neurological Disorder Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Neurological Disorder Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

      By Company
      Novartis
      GlaxoSmithKline
      Merck & Co.
      Bayer
      AstraZeneca
      Boehringer Ingelheim
      Teva Pharmaceutical

      Buy now